News
Why Vaxxinity Shares Are Trading Lower By Around 55%? Here Are Other Stocks Moving In Monday's Mid-Day Session
22 Apr 24
News, Intraday Update, Markets, Movers
Why Wang & Lee Group Shares Are Trading Higher By 38%; Here Are 20 Stocks Moving Premarket
19 Apr 24
News, Pre-Market Outlook, Markets, Movers
12 Health Care Stocks Moving In Thursday's After-Market Session
18 Apr 24
Movers
Bio-Path Holdings Announces $1.2M Registered Direct Offering With Some Institutional Investors For Sale Of 375,000 Shares Of Its Common Stock At Price Of $3.225/Share
18 Apr 24
News, Offerings
Roth MKM Reiterates Buy on Bio-Path Hldgs, Maintains $40 Price Target
18 Apr 24
News, Price Target, Reiteration, Analyst Ratings
Why Bio-Path Stock Is Soaring
18 Apr 24
News, Movers
12 Health Care Stocks Moving In Thursday's Intraday Session
18 Apr 24
Movers
Crude Oil Edges Lower; Bio-Path Holdings Shares Spike Higher
18 Apr 24
Earnings, News, Intraday Update, Markets, Movers
Why Las Vegas Sands Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
18 Apr 24
Earnings, News, Markets, Movers
Dow Surges Over 100 Points; D.R. Horton Posts Upbeat Earnings
18 Apr 24
Earnings, News, Penny Stocks, Eurozone, Commodities, Small Cap, Global, Intraday Update, Markets, Trading Ideas
Market-Moving News for April 18th
18 Apr 24
Movers, Trading Ideas
12 Health Care Stocks Moving In Thursday's Pre-Market Session
18 Apr 24
Movers
Bio-Path Holdings Reveals Receipt Of Newly Issued Patents In Mexico, Australia And Japan
15 Apr 24
News
Why Bio-Path Holdings Shares Are Falling Today
8 Mar 24
Earnings, Equities, News, Guidance, Top Stories, Markets, Movers, General
Earnings Scheduled For March 8, 2024
8 Mar 24
Earnings
12 Health Care Stocks Moving In Thursday's After-Market Session
7 Mar 24
Movers
Bio-Path Holdings's Earnings: A Preview
7 Mar 24
Earnings
Press releases
Bio-Path Holdings, Inc. Announces Closing of $1.2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
19 Apr 24
News, Financing, Press Releases
Bio-Path Holdings, Inc. Announces $1.2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
18 Apr 24
News, Financing, Press Releases
Bio-Path Holdings Announces Successful Completion of Higher Dose Second Cohort in Phase 1/1b Clinical Trial of BP1002 in Refractory/Relapsed Acute Myeloid Leukemia (AML) Patients
18 Apr 24
Health Care, Press Releases
Bio-Path Holdings Provides 2024 Clinical and Operational Update
2 Apr 24
Health Care, Press Releases, General
Bio-Path Holdings Reports Full Year 2023 Financial Results
8 Mar 24
Earnings, Press Releases
Bio-Path Holdings to Announce Fourth Quarter and Full Year 2023 Financial Results on March 8, 2024
1 Mar 24
Press Releases